Updated Jul 16, 2026
SCHLACKMAN SCOTT has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $63K.
Scott Schlackman is listed as a director of Medifast, Inc. in the SEC filing dated May 12, 2026. The available context confirms his role on Medifast's board of directors as of that filing. Other biographical details (education, career history, prior board service) are not provided in the context given.
| Role | Director |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | MED | MEDIFAST INC | A — Grant or award | 11.7K | $0.00 | |
| 2026-05-12 | MED | MEDIFAST INC | P — Open-market purchase | 2.5K | $12.53 | $31K |
| 2026-05-12 | MED | MEDIFAST INC | P — Open-market purchase | 2.5K | $12.65 | $32K |
Scott Schlackman is listed as a director of Medifast, Inc. in the SEC filing dated May 12, 2026. The available context confirms his role on Medifast's board of directors as of that filing. Other biographical details (education, career history, prior board service) are not provided in the context given.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($63K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SCHLACKMAN SCOTT profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.